Physician

Hassan Asghar Jafary, MD

According to 2025 Medicare claims, Hassan Jafary, MD (NPI: 1740398239) practices internal medicine in the Beckley, WV market, with the plurality of this provider's patient population coming from Raleigh, WV. This provider's primary affiliated billing organization is ALWAHIDO MEDICAL CORPORATION M C (NPI: 1467542183; TIN: 020635990) and primary practice location at 25801-3145.

Jafary's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 153 traditional Medicare patients, billed 3,071 HCPCS/CPT codes, and received $104,723 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 13,608 prescription claims across 354 beneficiaries totaling $775,077 in drug costs, led by Eliquis (Apixaban). DME data shows 279 claims. Open Payments data shows 22 records totaling $465. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $199,219 to $104,723. Concurrently, Part D prescription costs have changed little. For DME billing, reported payments moved up and down with repeated peaks and valleys, starting at $17,618 and ending at $56,510.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	328	4,958	$199,219
2016	313	4,256	$175,612
2017	298	3,098	$138,820
2018	279	2,905	$119,967
2019	260	3,527	$129,489
2020	234	3,646	$137,751
2021	203	3,006	$128,278
2022	194	3,248	$134,279
2023	177	3,307	$120,923
2024	153	3,071	$104,723

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	476	15,584	$1,048,160
2016	441	14,817	$982,463
2017	424	14,511	$924,047
2018	399	13,935	$965,861
2019	398	11,999	$860,208
2020	346	11,094	$720,800
2021	340	10,434	$668,255
2022	344	11,035	$683,609
2023	354	12,036	$850,077
2024	354	13,608	$775,077

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	147	444	$14,497
2016	147	500	$10,997
2017	97	478	$8,143
2018	54	374	$6,775
2019	37	282	$7,175
2020	15	170	$4,794
2021	16	154	$5,414
2022	13	212	$9,505
2023	12	246	$14,544
2024	12	279	$55,398

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	30	30	$121
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	126	535	$78
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	129	595	$59
99212	Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more	83	154	$38
J1100	Injection, dexamethasone sodium phosphate, 1 mg	56	1,309	$0

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	156	5,976	$111,380
Ozempic	Semaglutide	105	3,428	$104,292
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	54	1,980	$42,208
Tresiba Flextouch U-200	Insulin Degludec	23	1,042	$35,959
Xarelto	Rivaroxaban	46	1,574	$28,939

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0483	High frequency chest wall oscillation system, with full anterior and/or posterior thoracic region receiving simultaneous external oscillation, includes all accessories and supplies, each	Y	N/R	20	$19,618
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	N/R	12	$12,253
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	21	$12,095
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	12	90	$8,298
E1392	Portable oxygen concentrator, rental	Y	N/R	49	$1,824

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	22	$465	Lundbeck LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Hassan Asghar Jafary, MD?

Tedicare shows public-source Medicare data for Hassan Asghar Jafary, MD (NPI 1740398239), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Hassan Asghar Jafary, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Hassan Asghar Jafary, MD?

Hassan Asghar Jafary, MD is linked to ALWAHIDO MEDICAL CORPORATION M C (billing NPI 1467542183) in the available physician profile data.

Does Hassan Asghar Jafary, MD have Open Payments data?

Hassan Asghar Jafary, MD has 22 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.